# Tilray Brands, Inc.: filings

TLRY · Nasdaq · CIK 1731348 · [Healthcare](/sectors/healthcare.md) · fiscal year ends May 31

Pages: [Overview](/companies/tlry.md) · [Financials](/companies/tlry/financials.md) · [Filings](/companies/tlry/filings.md) · [Insiders](/companies/tlry/insiders.md)

## Reports and events: 231 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 299, 8-K 159, DEFA14A 83, 3 28, 10-Q 26, 424B7 21, 8-K/A 11, 425 10, DEF 14A 10, UPLOAD 10, 10-K 9, CORRESP 9, S-8 9, 424B5 8, PRE 14A 8, 4/A 7, SC 13D/A 7, FWP 5, SC 13G 5, SC 13G/A 5, ARS 4, S-3ASR 4, 10-K/A 3, SC 13D 3, 424B2 2, 424B3 2, 424B4 2, DRS/A 2, DRSLTR 2, EFFECT 2, S-1/A 2, 144 1, 305B2 1, 8-A12B 1, 8-A12B/A 1, CERT 1, CT ORDER 1, D 1, DEFM14A 1, DRS 1, PREM14A 1, S-1 1, S-4 1, S-4/A 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-08 | 21:00 ET | [10-Q](/filings/0001437749-26-032382.md) | Quarterly report, period 2026-08-31 | 0001437749-26-032382 |
| 2026-10-08 | 11:00 ET | [8-K](/filings/0001171843-26-006527.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001171843-26-006527 |
| 2026-09-28 | 20:00 ET | [DEF 14A](/filings/0001140361-26-037827.md) | Proxy statement, period 2026-11-18 | 0001140361-26-037827 |
| 2026-09-14 | 21:12 ET | [8-K](/filings/0001140361-26-036507.md) | 3.02 Unregistered sale of equity | 0001140361-26-036507 |
| 2026-08-10 | 21:00 ET | [8-K](/filings/0001140361-26-032052.md) | 3.02 Unregistered sale of equity | 0001140361-26-032052 |
| 2026-07-28 | 21:03 ET | [10-K](/filings/0001437749-26-024698.md) | Annual report, period 2026-05-31 | 0001437749-26-024698 |
| 2026-07-28 | 20:05 ET | [8-K](/filings/0001171843-26-004944.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001171843-26-004944 |
| 2026-06-30 | 21:01 ET | [8-K](/filings/0001140361-26-026966.md) | 3.02 Unregistered sale of equity | 0001140361-26-026966 |
| 2026-06-09 | 20:31 ET | [8-K](/filings/0001140361-26-024650.md) | 3.02 Unregistered sale of equity | 0001140361-26-024650 |
| 2026-04-21 | 20:40 ET | [8-K](/filings/0001140361-26-015921.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-26-015921 |
| 2026-04-15 | 12:54 ET | [8-K](/filings/0001140361-26-014692.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001140361-26-014692 |
| 2026-04-15 | 22:27 ET | [8-K](/filings/0001140361-26-014638.md) | 3.02 Unregistered sale of equity | 0001140361-26-014638 |
| 2026-04-01 | 20:30 ET | [10-Q](/filings/0001437749-26-010907.md) | Quarterly report, period 2026-02-28 | 0001437749-26-010907 |
| 2026-04-01 | 11:00 ET | [8-K](/filings/0001171843-26-002136.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001171843-26-002136 |
| 2026-03-02 | 21:31 ET | [8-K](/filings/0001437749-26-006389.md) | 1.01 Entry into a material agreement; 2.01 Completion of an acquisition or disposition; 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-26-006389 |
| 2026-01-08 | 22:03 ET | [10-Q](/filings/0001437749-26-000902.md) | Quarterly report, period 2025-11-30 | 0001437749-26-000902 |
| 2026-01-08 | 21:20 ET | [8-K](/filings/0001171843-26-000146.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001171843-26-000146 |
| 2025-11-26 | 21:10 ET | [8-K](/filings/0001437749-25-036448.md) | 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-25-036448 |
| 2025-11-19 | 21:30 ET | [8-K](/filings/0001437749-25-035739.md) | 5.07 Shareholder vote results | 0001437749-25-035739 |
| 2025-11-17 | 22:06 ET | [8-K](/filings/0001437749-25-035455.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-25-035455 |
| 2025-10-09 | 21:12 ET | [10-Q](/filings/0001437749-25-030797.md) | Quarterly report, period 2025-08-31 | 0001437749-25-030797 |
| 2025-10-09 | 11:01 ET | [8-K](/filings/0001171843-25-006368.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001171843-25-006368 |
| 2025-09-26 | 21:01 ET | [DEF 14A](/filings/0001140361-25-036324.md) | Proxy statement, period 2025-11-18 | 0001140361-25-036324 |
| 2025-09-10 | 20:32 ET | [8-K](/filings/0001140361-25-034569.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-25-034569 |
| 2025-07-29 | 23:22 ET | [10-K](/filings/0001437749-25-023703.md) | Annual report, period 2025-05-31 | 0001437749-25-023703 |
| 2025-07-28 | 20:32 ET | [8-K](/filings/0001171843-25-004746.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001171843-25-004746 |
| 2025-06-23 | 20:10 ET | [8-K](/filings/0001437749-25-021037.md) | 3.02 Unregistered sale of equity | 0001437749-25-021037 |
| 2025-06-10 | 21:00 ET | [8-K](/filings/0001140361-25-022089.md) | 5.07 Shareholder vote results | 0001140361-25-022089 |
| 2025-04-28 | 20:53 ET | [DEF 14A](/filings/0001140361-25-016065.md) | Proxy statement, period 2025-06-10 | 0001140361-25-016065 |
| 2025-04-25 | 20:06 ET | [8-K](/filings/0001140361-25-015720.md) | 3.02 Unregistered sale of equity | 0001140361-25-015720 |
| 2025-04-17 | 11:42 ET | [8-K](/filings/0001437749-25-012217.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-25-012217 |
| 2025-04-08 | 21:01 ET | [10-Q](/filings/0001437749-25-011431.md) | Quarterly report, period 2025-02-28 | 0001437749-25-011431 |
| 2025-04-08 | 11:00 ET | [8-K](/filings/0001171843-25-002081.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001171843-25-002081 |
| 2025-03-25 | 20:35 ET | [8-K](/filings/0001437749-25-009162.md) | 3.01 Delisting notice | 0001437749-25-009162 |
| 2025-03-10 | 21:06 ET | [8-K](/filings/0001437749-25-006857.md) | 3.02 Unregistered sale of equity | 0001437749-25-006857 |
| 2025-02-26 | 21:34 ET | [8-K](/filings/0001437749-25-005242.md) | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001437749-25-005242 |
| 2025-02-07 | 21:31 ET | [8-K](/filings/0001437749-25-003171.md) | 8.01 Other events | 0001437749-25-003171 |
| 2025-02-06 | 21:05 ET | [8-K](/filings/0001140361-25-003428.md) | 3.02 Unregistered sale of equity | 0001140361-25-003428 |
| 2025-01-10 | 21:57 ET | [10-Q](/filings/0001437749-25-000868.md) | Quarterly report, period 2024-11-30 | 0001437749-25-000868 |
| 2025-01-10 | 12:00 ET | [8-K](/filings/0001171843-25-000152.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001171843-25-000152 |
| 2024-12-19 | 21:11 ET | [8-K](/filings/0001437749-24-037950.md) | 5.07 Shareholder vote results | 0001437749-24-037950 |
| 2024-12-13 | 21:17 ET | [8-K](/filings/0001437749-24-037479.md) | 5.02 Departure or appointment of officers or directors | 0001437749-24-037479 |
| 2024-12-02 | 14:01 ET | [8-K](/filings/0001437749-24-036395.md) | 8.01 Other events | 0001437749-24-036395 |
| 2024-11-21 | 21:05 ET | [8-K](/filings/0001437749-24-035954.md) | 5.07 Shareholder vote results | 0001437749-24-035954 |
| 2024-11-06 | 22:02 ET | [8-K](/filings/0001140361-24-045431.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-24-045431 |
| 2024-11-01 | 20:34 ET | [8-K](/filings/0001437749-24-032999.md) | 1.01 Entry into a material agreement | 0001437749-24-032999 |
| 2024-10-10 | 13:11 ET | [10-Q](/filings/0001437749-24-031040.md) | Quarterly report, period 2023-08-31 | 0001437749-24-031040 |
| 2024-10-10 | 21:05 ET | [10-Q](/filings/0001437749-24-031042.md) | Quarterly report, period 2024-08-31 | 0001437749-24-031042 |
| 2024-10-10 | 11:00 ET | [8-K](/filings/0001171843-24-005585.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001171843-24-005585 |
| 2024-09-27 | 20:17 ET | [DEF 14A](/filings/0001140361-24-042191.md) | Proxy statement, period 2024-11-21 | 0001140361-24-042191 |

Page 1 of 5. [Older](/companies/tlry/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:07 ET. No prices; not investment advice.